Real-time enrollment status for this relapsed acute myeloid leukemia (aml) clinical trial
Current Status
Recruiting
Checked: October 17, 2026 at 9:53 PM UTC
| NCT Number | NCT06846606 |
| Recruiting Status | Recruiting |
| Condition | Relapsed Acute Myeloid Leukemia (AML) |
| Phase | PHASE1 |
| Target Enrollment | 69 participants |
| Active Locations | 9 sites in the US |
| Sponsor | Auron Therapeutics, Inc. |
| Last Updated on CT.gov | October 16, 2026 (Yesterday) |
As of October 17, 2026: Clinical trial NCT06846606 is currently recruiting participants. This phase1 study for relapsed acute myeloid leukemia (aml) is actively seeking new participants at 9 locations across the United States. The study is sponsored by Auron Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06846606 is actively recruiting participants as of October 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 9 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06846606 was last updated Yesterday (October 16, 2026). HelloStudys verifies this status automatically.